Filing Flows › Comparisons › CNSY vs PLSE
Cerenome vs Pulse Biosciences: CNSY and PLSE compared
Cerenome is the larger company: $411K of revenue in its latest quarter (Q2 2026) against $395K for Pulse Biosciences (Q3 2026). Pulse Biosciences is growing faster (+359% against -70% a year earlier).
Where the money goes: CNSY and PLSE
Cerenome (CNSY) · Q2 2026
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart follows the revenue to costs, profit and cash.
Pulse Biosciences (PLSE) · Q3 2026
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
| Cerenome (CNSY) | Pulse Biosciences (PLSE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $411K | $395K |
| Revenue growth, Y/Y | -70% | +359% |
| Operating margin | n/m | n/m |
| Net earnings | −$9.0M | −$23.1M |
| Operating cash flow | −$7.1M | −$15.3M |
Questions
Which is bigger, Cerenome or Pulse Biosciences?
Cerenome is the larger company: $411K of revenue in its latest quarter (Q2 2026) against $395K for Pulse Biosciences (Q3 2026).
Is Cerenome or Pulse Biosciences growing faster?
Pulse Biosciences is growing faster (+359% against -70% a year earlier).
More: Cerenome earnings · how Cerenome makes money · Pulse Biosciences earnings · how Pulse Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.